The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Potential Anti-inflammatory Effects of Proton Pump Inhibitors: A Review and Discussion of the Clinical Implications
Open accessAbstract
Proton pump inhibitors (PPIs) are potent blockers of gastric acid secretion, and are widely regarded as the agents of choice for the treatment of acid-peptic disorders. For patients with upper gastrointestinal symptoms of uncertain etiology, improvement with PPI therapy is considered prima facie evidence of a pathogenetic role for acid-peptic disease. In addition to anti-secretory effects, however, PPIs have been found to have anti-oxidant properties and direct effects on neutrophils, monocytes, endothelial, and epithelial cells that might prevent inflammation. Those anti-inflammatory effects of the PPIs might influence a variety of inflammatory disorders, both peptic and non-peptic, within and outside of the gastrointestinal tract. The purpose of this report is to review the mechanisms whereby PPIs might exert anti-inflammatory effects exclusive of gastric acid inhibition, to discuss the clinical implications of those effects, and to emphasize that a clinical response to PPIs should not be construed as proof for an underlying acid-peptic disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Furuta, G. T., Liacouras, C. A., Collins, M. H., Gupta, S. K., Justinich, C., Putnam, P. E., Bonis, P., Hassall, E., Straumann, A., & Rothenberg, M. E. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.017 · Cited by 1,673
Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive Drugs
Laheij, R. J. F. (2004) · JAMA · doi:10.1001/jama.292.16.1955 · Cited by 877
Li, X.-Q., Andersson, T. B., Ahlström, M., & Weidolf, L. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.8.821 · Cited by 644
Overprescribing proton pump inhibitors
Forgacs, I., & Loganayagam, A. (2008) · BMJ · doi:10.1136/bmj.39406.449456.be · Cited by 553
Pharmacology of proton pump inhibitors
Shin, J. M., & Sachs, G. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0098-4 · Cited by 538
Acid-suppressive medication use and the risk for hospital-acquired pneumonia
Herzig, S. J. (2009) · JAMA · doi:10.1001/jama.2009.722 · Cited by 486 · cited 1×
“Perhaps such actions might underlie the predisposition to both community- and hospital-acquired pneumonia that has been described for patients who take PPIs [47, 48].”
Effect of Proton Pump Inhibitor Pretreatment on Resistance of Solid Tumors to Cytotoxic Drugs
Luciani, F., Spada, M., De Milito, A., Molinari, A., Rivoltini, L., Montinaro, A., Marra, M., Lugini, L., Logozzi, M., Lozupone, F., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh305 · Cited by 435
Spechler, S. J., Genta, R. M., & Souza, R. F. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01179.x · Cited by 358
Self-citationOxygen, ischemia and inflammation.
Weiss, S. J. (1986) · PubMed · Cited by 308
Ngo, P., Furuta, G. T., Antonioli, D. A., & Fox, V. L. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00562.x · Cited by 306
Biswas, K., Bandyopadhyay, U., Chattopadhyay, I., Varadaraj, A., Ali, E., & Banerjee, R. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210328200 · Cited by 291
Interleukin-8 induces neutrophil transendothelial migration.
Smith, W., Gamble, J. R., Clark‐Lewis, I., & Vadas, M. A. (1991) · PubMed · Cited by 233
Bajaj, J. S., Zadvornova, Y., Heuman, D. M., Hafeezullah, M., Hoffmann, R. G., Sanyal, A. J., & Saeian, K. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.80 · Cited by 219
Zedtwitz-Liebenstein, K., Wenisch, C., Patruta, S., Parschalk, B., Daxböck, F., & Graninger, W. (2002) · Critical Care Medicine · doi:10.1097/00003246-200205000-00026 · Cited by 206
Lafourcade, C., Sobo, K., Kieffer-Jaquinod, S., Garin, J., & van der Goot, F. G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002758 · Cited by 197
Yoshida, N., Yoshikawa, T., Tanaka, Y., Fujita, N., Kassai, K., Naito, Y., & Kondo, M. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.014s1074.x · Cited by 190
Wandall, J. H. (1992) · Gut · doi:10.1136/gut.33.5.617 · Cited by 179
The Effect of Proton Pump Inhibitors on the Human Microbiota
Vesper, B. J., Jawdi, A., Altman, K. W., Haines, G. K., Tao, L., & Radosevich, J. A. (2009) · Current Drug Metabolism · doi:10.2174/138920009787048392 · Cited by 154
Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds.
Verdu, E. F., Viani, F., Armstrong, D., Fraser, R., Siegrist, H. H., Pignatelli, B., Idström, J., Cederberg, C., Blum, A. L., & Fried, M. (1994) · Gut · doi:10.1136/gut.35.4.455 · Cited by 136
Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors
Handa, O., Yoshida, N., Fujita, N., Tanaka, Y., Ueda, M., Takagi, T., Kokura, S., Naito, Y., Okanoue, T., & Yoshikawa, T. (2006) · Inflammation Research · doi:10.1007/s00011-006-6056-4 · Cited by 120
Omeprazole attenuates oxygen-derived free radical production from human neutrophils
Suzuki, M., Mori, M., Miura, S., Suematsu, M., Fukumura, D., Kimura, H., & Ishii, H. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)00180-3 · Cited by 114
Ritter, M., Schratzberger, P., Rossmann, H., Wöll, E., Seiler, K., Seidler, U. E., Reinisch, N., Kähler, C. M., Zwierzina, H., Lang, H. J., et al. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701864 · Cited by 94
Agastya, G., West, B. C., & Callahan, J. M. (2000) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970009016425 · Cited by 91
Antioxidant properties of omeprazole
Lapenna, D., de Gioia, S., Ciofani, G., Festi, D., & Cuccurullo, F. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00155-x · Cited by 85
Becker, J. C., Grosser, N., Waltke, C., Schulz, S., Erdmann, K., Domschke, W., Schröder, H., & Pohle, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.170 · Cited by 83
Rafiee, P., Theriot, M., Nelson, V. M., Heidemann, J., Kanaa, Y., Horowitz, S. A., Rogaczewski, A., Johnson, C. P., Ali, I., Shaker, R., et al. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00474.2005 · Cited by 79
Monk, B. C., Mason, A. B., Abramochkin, G., Haber, J. E., Seto‐Young, D., & Perlin, D. S. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00133-n · Cited by 78
Nαkαo, M., & Malfertheiner, P. (1998) · Helicobacter · doi:10.1046/j.1523-5378.1998.08024.x · Cited by 75
Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis
Kuroda, M., Yoshida, N., Ichikawa, H., Takagi, T., Okuda, T., Naito, Y., Okanoue, T., & Yoshikawa, T. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.1.89 · Cited by 69
Sasaki, T., Yamaya, M., Yasuda, H., Inoue, D., Yamada, M., Kubo, H., Nishimura, H., & Sasaki, H. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.12.042 · Cited by 61
Inhibition of neutrophil oxidative metabolism by lysosomotropic weak bases
Styrt, B. A., & Klempner, M. S. (1986) · Blood · doi:10.1182/blood.v67.2.334.334 · Cited by 58
Hydroxyl radical scavenging reactivity of proton pump inhibitors
Simon, W. A., Sturm, E., Hartmann, H., & Weser, U. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.01.009 · Cited by 58
Strober, W. (2006) · Science · doi:10.1126/science.1131997 · Cited by 51
de Oliveira, R. M., Antunes, E., Pedrazzoli, J., & Gambero, A. (2007) · Inflammation Research · doi:10.1007/s00011-006-6127-6 · Cited by 50
Treatment of Eosinophilic Esophagitis: Overview, Current Limitations, and Future Direction
Bohm, M. E., & Richter, J. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02116.x · Cited by 47
Integrated Approach to Treatment of Children and Adults With Eosinophilic Esophagitis
Aceves, S. S., Furuta, G. T., & Spechler, S. J. (2007) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2007.09.003 · Cited by 41
Self-citationLansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats
Ichikawa, H., Yoshida, N., Takagi, T., Tomatsuri, N., Katada, K., Isozaki, Y., Uchiyama, K., Naito, Y., Okanoue, T., & Yoshikawa, T. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i19.2814 · Cited by 38
Harada, M., Shakado, S., Sakisaka, S., Tamaki, S., Ohishi, M., Sasatomi, K., Koga, H., Sata, M., & Tanikawa, K. (1997) · Liver International · doi:10.1111/j.1600-0676.1997.tb01025.x · Cited by 34
Cited by
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
Liacouras, C. A., Furuta, G. T., Hirano, I., Atkins, D., Attwood, S. E., Bonis, P. A., Burks, A. W., Chehade, M., Collins, M. H., Dellon, E. S., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.02.040 · Cited by 2,073
Self-citationDellon, E. S., Liacouras, C. A., Molina-Infante, J., Furuta, G. T., Spergel, J. M., Zevit, N., Spechler, S. J., Attwood, S. E., Straumann, A., Aceves, S. S., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.009 · Cited by 1,162
Self-citationfor the SIF-AIGO-FIMMG Group, Scarpignato, C., on behalf of the Italian Society of Pharmacology, T. I. A. O. H. G., Gatta, L., Zullo, A., & Blandizzi, C. (2016) · BMC Medicine · doi:10.1186/s12916-016-0718-z · Cited by 469
Cheng, E., Zhang, X., Huo, X., Yu, C., Zhang, Q., Wang, D. H., Spechler, S. J., & Souza, R. F. (2013) · Gut · doi:10.1136/gutjnl-2012-302250 · Cited by 348
Self-citationMolina-Infante, J., Bredenoord, A. J., Cheng, E., Dellon, E. S., Furuta, G. T., Gupta, S. K., Hirano, I., Katzka, D. A., Moawad, F. J., Rothenberg, M. E., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310991 · Cited by 326
Self-citation
Metadata
- Authors
- Kedika, R. R., Souza, R. F., & Spechler, S. J.
- Venue
- Digestive Diseases and Sciences
- Published
- 2009-08-28
- Volume
- 54
- Issue
- 11
- Pages
- 2312-2317
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2025605750
- Cited by
- 324
- References
- 38
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.